Shots:
- The Phenomix’s MyPhenome test utilize phenotype-driven multi-omics technology to analyze genomics, metabolomics, and hormone levels and use AI-driven algorithmic tool to identify four specific obesity phenotypes, giving doctors the ability to prescribe more precise anti-obesity treatments
- The study showed that phenotype-specific obesity resulted in nearly double the weight loss over the treatment course of 1yr.
- Phenomix has identified the four primary phenotypes i.e Hungry Brain, Hungry Gut, Emotional Hunger, and Slow Burn that encompass more than 90% of obesity cases. The company expects the launch of the MyPhenome test in 2021, once its CLIA laboratory process is complete
Click here to read full press release/ article | Ref: BUSINESS WIRE | Image: Phenomix
The post Phenomix Collaborates with Mayo Clinic for AI-Powered Obesity Phenotype Blood Test first appeared on PharmaShots.
